Astellas, Potenza ally in immuno-oncology therapies; Astellas later acquires company
Astellas Pharma Inc. and Potenza Therapeutics Inc. teamed up to discover and develop cancer immunotherapies that target immune checkpoint pathways, co-stimulatory signals, and regulatory T cells.
- Includes Equity
- Includes M&A Option
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com